Press Release: MolecuLight Ranked in the Top 6 at the 2016 Medical Design Excellence Awards

Toronto, June 21, 2016: The Medical Design Excellence Awards (MDEA), the premier awards program for the medtech industry announced the 2016 winners on Tuesday, June 14th at a special ceremony at the MD&M East conference and exposition in New York City.

This was the 18th Edition of the Award Program that recognizes significant achievement in medical product design and engineering that improve the quality of healthcare delivery and accessibility.

The Award program honored innovation across 9 categories. MolecuLight was one of the finalists for the Diagnostic Product and Systems category. The company’s device, its first product, MolecuLight i:XTM ranked in the top 6 in that category.

About MolecuLight:
Founded in 2012, and based in Toronto, Canada, MolecuLight Inc. is a privately-owned medical imaging company delivering fluorescence image-guidance solutions that provide clinicians with new information about wound bacterial burden for better diagnostic and treatment decisions.
MolecuLight strives to become the ubiquitous name in fluorescence-guided wound imaging technologies and to serve the healthcare industry with world-class products and services while delivering value to all customers, employees and shareholders.

Note: The MolecuLight i:XTM Imaging Device is approved by Health Canada (Medical License #95784). The MolecuLight i:XTM Imaging Device is pending 510(k) clearance and CE mark approval and is not approved for use in the US or EU.

Media Contact:
Catherine Theodoropoulos, PhD, VP Marketing & Product Strategy
catherinet@moleculight.com